Viewing Study NCT04644250


Ignite Creation Date: 2025-12-24 @ 5:14 PM
Ignite Modification Date: 2025-12-25 @ 6:01 PM
Study NCT ID: NCT04644250
Status: UNKNOWN
Last Update Posted: 2020-11-25
First Post: 2020-11-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Combination of Toripalimab and Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Sponsor: Wei Ren
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: GLYY-EC-NAD-01
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators